Dr. Felix Filias, MD

Dr. Filias practices at Martin Health Physician Group - HOPD in Port Saint Lucie, Florida.

Dr. Filias' NPI, 1063073658, was assigned on June 24, 2019. Dr. Filias graduated from Pontificia Universidad Católica Madre y Maestra in 2011. Dr. Filias holds Florida license 153525.

Dr. Filias' primary practice is Martin Health Physician Group - HOPD, at 10000 Sw Innovation Way, Port Saint Lucie, FL 34987.

Dr. Filias' primary practice is Martin Health Physician Group - HOPD in Port Saint Lucie, Florida. Dr. Filias is also affiliated with Cleveland Clinic Martin North Hospital. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Filias to 3 more group practices and clinics, 2 medical groups and 1 hospice, each named with a free account. Dr. Filias' employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Filias practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Filias' primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Filias is board certified in internal medicine by the American Board of Internal Medicine. Dr. Filias is licensed in Florida.

Dmand AI lists acute diabetes, acute respiratory failure, atherosclerosis, cardiac arrhythmia, cellulitis, chest pain, chronic anemia and chronic kidney disease among the conditions Dr. Filias treats.

CMS data shows 722 Medicare services from Dr. Filias across 6 procedure codes in 2024, for 287 Medicare patients. Medicare paid $60,394 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 287 Medicare patients who saw Dr. Filias in 2024. The largest group is 75 to 84, with 137 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Filias' median patient age at 70, with 55% women.

In 2024, Dr. Filias wrote 524 Medicare Part D claims for 250 patients. 82% of them were for generic drugs. CMS names the drug for 248 of them, across 14 drugs with 11 or more claims each, at $16,074 in total drug cost. In 2023, CMS named 190 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Filias for performance year 2024, reported through an alternative payment model (APM). Dr. Filias accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 30 general payments to Dr. Filias from 1 drug or device company from 2022 to 2024. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,121.

Dr. Filias graduated from Pontificia Universidad Católica Madre y Maestra in 2011.

Dr. Filias is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.